News

Staburo’s Isar picnic

Staburo’s Isar picnic

Since we all still work mainly from home, we were really looking forward to having a picnic together on the Isar – in the fresh air and with a lot of distance. Unfortunately, the weather didn’t quite play along, so we had to move our event from the Isar to our office courtyard equipped with large umbrellas.

read more
JCO Published Results of Staburo-Supported Study Investigating Stem Cell Transplantation as a Reasonable Treatment Option for Older MDS Patients

JCO Published Results of Staburo-Supported Study Investigating Stem Cell Transplantation as a Reasonable Treatment Option for Older MDS Patients

The results of the so-called VidazaAllo Study – with Universitätsklinikum Hamburg-Eppendorf (UKE) being the sponsor – has been published by the Journal of Clinical Oncology (JCO) on July 20. The key objective of the VidazaAllo Study was: Can allogenic stem cell transplantation (HSCT) in older patients with myelodysplastic syndromes (MDS) improve overall survival in comparison with standard 5-azacytidine (Vidaza) therapy?

read more
Estimands Online Workshop

Estimands Online Workshop

The gold standard for evaluating medical interventions is a randomised clinical trial with statistical analysis based on the intention-to-treat population. However, even if a randomised clinical trial is well planned, post-randomisation events occur and affect or even challenge the interpretation and validity of the study results.

read more
New Staburo Office

New Staburo Office

We took the opportunity to move to a bigger office space recently. The move was – due to home-office as current preferred way of working – logistically easier to perform than expected. We now rent a much bigger space than before and thanks to the top floor location, it has a very light and airy feel!

read more